Why Synthetic CBD Is (Probably) the Future of Cannabis Pharma

While there is a race among cannabis cultivators to have the largest greenhouse in the world, the race is on for medical cannabis biotechs to create a synthetic form of CBD, one that is not derived from the cannabis plant, but cooked up in a lab.

Greenhouses packed with those verdant, pungent plants could become relics of the past, because if you’re a medical cannabis patient, it’s not the plant that you need, it’s the cannabinoids — and both THC and CBD can be synthesized. For medical marijuana pharmaceutical companies, synthetic cannabinoids could cut massive costs of growing the plant and quicken the FDA approval process. The first company to create and patent a CBD compound would command a serious edge in this fast-growing industry.

To read more…

Share This Post

Related Articles

Leave a Reply

© 2019 Medical Marijuana Stocks. All rights reserved. Site Admin · Entries RSS · Comments RSS
Powered by WordPress · Designed by Theme Junkie